nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CYP2D6—Niacin—atherosclerosis	0.106	0.169	CbGbCtD
Ciclesonide—CYP2D6—Simvastatin—atherosclerosis	0.084	0.134	CbGbCtD
Ciclesonide—CYP2D6—Pravastatin—atherosclerosis	0.0822	0.131	CbGbCtD
Ciclesonide—CYP2D6—Lovastatin—atherosclerosis	0.0822	0.131	CbGbCtD
Ciclesonide—CYP3A4—Rosuvastatin—atherosclerosis	0.0574	0.0916	CbGbCtD
Ciclesonide—CYP3A4—Ezetimibe—atherosclerosis	0.0574	0.0916	CbGbCtD
Ciclesonide—CYP3A4—Simvastatin—atherosclerosis	0.0534	0.0851	CbGbCtD
Ciclesonide—CYP3A4—Pravastatin—atherosclerosis	0.0523	0.0833	CbGbCtD
Ciclesonide—CYP3A4—Lovastatin—atherosclerosis	0.0523	0.0833	CbGbCtD
Ciclesonide—CES1—Phase I biotransformations, non P450—PON3—atherosclerosis	0.0504	0.269	CbGpPWpGaD
Ciclesonide—CES1—Phase I biotransformations, non P450—PON2—atherosclerosis	0.0324	0.173	CbGpPWpGaD
Ciclesonide—CES1—Irinotecan Pathway—NPC1—atherosclerosis	0.0244	0.13	CbGpPWpGaD
Ciclesonide—CES1—Phase I biotransformations, non P450—PON1—atherosclerosis	0.017	0.0911	CbGpPWpGaD
Ciclesonide—Gamma-glutamyltransferase increased—Ezetimibe—atherosclerosis	0.00362	0.0195	CcSEcCtD
Ciclesonide—CYP3A4—Irinotecan Pathway—NPC1—atherosclerosis	0.00322	0.0172	CbGpPWpGaD
Ciclesonide—Cataract—Lovastatin—atherosclerosis	0.00319	0.0172	CcSEcCtD
Ciclesonide—Gamma-glutamyltransferase increased—Pravastatin—atherosclerosis	0.00312	0.0168	CcSEcCtD
Ciclesonide—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.00299	0.0161	CcSEcCtD
Ciclesonide—Cataract—Simvastatin—atherosclerosis	0.00298	0.0161	CcSEcCtD
Ciclesonide—Gastroenteritis—Rosuvastatin—atherosclerosis	0.00293	0.0158	CcSEcCtD
Ciclesonide—Cataract—Pravastatin—atherosclerosis	0.00269	0.0145	CcSEcCtD
Ciclesonide—Diabetes mellitus—Simvastatin—atherosclerosis	0.00237	0.0128	CcSEcCtD
Ciclesonide—Swelling—Simvastatin—atherosclerosis	0.00233	0.0126	CcSEcCtD
Ciclesonide—Influenza—Rosuvastatin—atherosclerosis	0.00225	0.0121	CcSEcCtD
Ciclesonide—CYP3A4—Liver X Receptor Pathway—ABCG8—atherosclerosis	0.00221	0.0118	CbGpPWpGaD
Ciclesonide—Pain in extremity—Lovastatin—atherosclerosis	0.0022	0.0119	CcSEcCtD
Ciclesonide—Diabetes mellitus—Niacin—atherosclerosis	0.00217	0.0117	CcSEcCtD
Ciclesonide—Pain in extremity—Ezetimibe—atherosclerosis	0.00216	0.0116	CcSEcCtD
Ciclesonide—Bronchitis—Rosuvastatin—atherosclerosis	0.00216	0.0116	CcSEcCtD
Ciclesonide—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00195	0.0105	CcSEcCtD
Ciclesonide—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00193	0.0104	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.0019	0.0103	CcSEcCtD
Ciclesonide—Influenza—Lovastatin—atherosclerosis	0.0019	0.0103	CcSEcCtD
Ciclesonide—Sinusitis—Rosuvastatin—atherosclerosis	0.00188	0.0101	CcSEcCtD
Ciclesonide—Influenza—Ezetimibe—atherosclerosis	0.00187	0.0101	CcSEcCtD
Ciclesonide—Face oedema—Niacin—atherosclerosis	0.00183	0.00984	CcSEcCtD
Ciclesonide—Rhinitis—Rosuvastatin—atherosclerosis	0.0018	0.00972	CcSEcCtD
Ciclesonide—Pharyngitis—Rosuvastatin—atherosclerosis	0.00178	0.00962	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00173	0.00935	CcSEcCtD
Ciclesonide—Bronchitis—Simvastatin—atherosclerosis	0.00171	0.00923	CcSEcCtD
Ciclesonide—CES1—Fluoropyrimidine Activity—MTHFR—atherosclerosis	0.00169	0.00901	CbGpPWpGaD
Ciclesonide—Nasopharyngitis—Pravastatin—atherosclerosis	0.00166	0.00898	CcSEcCtD
Ciclesonide—Infestation NOS—Ezetimibe—atherosclerosis	0.00166	0.00897	CcSEcCtD
Ciclesonide—Infestation—Ezetimibe—atherosclerosis	0.00166	0.00897	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00165	0.00892	CcSEcCtD
Ciclesonide—Urinary tract infection—Lovastatin—atherosclerosis	0.00165	0.00889	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00164	0.00885	CcSEcCtD
Ciclesonide—Influenza—Niacin—atherosclerosis	0.00163	0.00881	CcSEcCtD
Ciclesonide—Influenza—Pravastatin—atherosclerosis	0.00161	0.00868	CcSEcCtD
Ciclesonide—Sinusitis—Lovastatin—atherosclerosis	0.00159	0.00858	CcSEcCtD
Ciclesonide—CYP3A4—Liver X Receptor Pathway—CYP7A1—atherosclerosis	0.00159	0.00847	CbGpPWpGaD
Ciclesonide—Bronchitis—Niacin—atherosclerosis	0.00157	0.00848	CcSEcCtD
Ciclesonide—Sinusitis—Ezetimibe—atherosclerosis	0.00156	0.00842	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.0015	0.00806	CcSEcCtD
Ciclesonide—Sinusitis—Simvastatin—atherosclerosis	0.00149	0.00803	CcSEcCtD
Ciclesonide—Pharyngitis—Ezetimibe—atherosclerosis	0.00148	0.008	CcSEcCtD
Ciclesonide—Weight increased—Pravastatin—atherosclerosis	0.00146	0.0079	CcSEcCtD
Ciclesonide—Angioedema—Rosuvastatin—atherosclerosis	0.00143	0.00771	CcSEcCtD
Ciclesonide—Urinary tract infection—Pravastatin—atherosclerosis	0.00139	0.00752	CcSEcCtD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—atherosclerosis	0.00139	0.00745	CbGpPWpGaD
Ciclesonide—CYP3A4—Liver X Receptor Pathway—ABCG5—atherosclerosis	0.00137	0.00733	CbGpPWpGaD
Ciclesonide—Cough—Rosuvastatin—atherosclerosis	0.00137	0.00736	CcSEcCtD
Ciclesonide—Immune system disorder—Ezetimibe—atherosclerosis	0.00135	0.00728	CcSEcCtD
Ciclesonide—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00135	0.00726	CcSEcCtD
Ciclesonide—Sinusitis—Pravastatin—atherosclerosis	0.00135	0.00726	CcSEcCtD
Ciclesonide—Arthralgia—Rosuvastatin—atherosclerosis	0.00133	0.00718	CcSEcCtD
Ciclesonide—Haemoglobin—Niacin—atherosclerosis	0.00131	0.00709	CcSEcCtD
Ciclesonide—Rhinitis—Niacin—atherosclerosis	0.00131	0.00707	CcSEcCtD
Ciclesonide—Haemorrhage—Niacin—atherosclerosis	0.00131	0.00705	CcSEcCtD
Ciclesonide—Dysgeusia—Lovastatin—atherosclerosis	0.0013	0.007	CcSEcCtD
Ciclesonide—Rhinitis—Pravastatin—atherosclerosis	0.00129	0.00696	CcSEcCtD
Ciclesonide—Back pain—Lovastatin—atherosclerosis	0.00128	0.00692	CcSEcCtD
Ciclesonide—Pharyngitis—Pravastatin—atherosclerosis	0.00128	0.00689	CcSEcCtD
Ciclesonide—Infection—Rosuvastatin—atherosclerosis	0.00127	0.00684	CcSEcCtD
Ciclesonide—Back pain—Ezetimibe—atherosclerosis	0.00126	0.00678	CcSEcCtD
Ciclesonide—Dysgeusia—Simvastatin—atherosclerosis	0.00121	0.00655	CcSEcCtD
Ciclesonide—Angioedema—Lovastatin—atherosclerosis	0.00121	0.00653	CcSEcCtD
Ciclesonide—Angioedema—Ezetimibe—atherosclerosis	0.00119	0.00641	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00116	0.00627	CcSEcCtD
Ciclesonide—Palpitations—Ezetimibe—atherosclerosis	0.00115	0.0062	CcSEcCtD
Ciclesonide—Cough—Ezetimibe—atherosclerosis	0.00113	0.00612	CcSEcCtD
Ciclesonide—Angioedema—Simvastatin—atherosclerosis	0.00113	0.00611	CcSEcCtD
Ciclesonide—Chest pain—Lovastatin—atherosclerosis	0.00113	0.00609	CcSEcCtD
Ciclesonide—Arthralgia—Lovastatin—atherosclerosis	0.00113	0.00609	CcSEcCtD
Ciclesonide—Dyspepsia—Rosuvastatin—atherosclerosis	0.00112	0.00606	CcSEcCtD
Ciclesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—atherosclerosis	0.00112	0.006	CbGpPWpGaD
Ciclesonide—Hypertension—Ezetimibe—atherosclerosis	0.00112	0.00605	CcSEcCtD
Ciclesonide—Arthralgia—Ezetimibe—atherosclerosis	0.00111	0.00597	CcSEcCtD
Ciclesonide—Chest pain—Ezetimibe—atherosclerosis	0.00111	0.00597	CcSEcCtD
Ciclesonide—Dry mouth—Lovastatin—atherosclerosis	0.0011	0.00595	CcSEcCtD
Ciclesonide—Dysgeusia—Pravastatin—atherosclerosis	0.0011	0.00592	CcSEcCtD
Ciclesonide—Dry mouth—Ezetimibe—atherosclerosis	0.00108	0.00584	CcSEcCtD
Ciclesonide—Infection—Lovastatin—atherosclerosis	0.00108	0.0058	CcSEcCtD
Ciclesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—atherosclerosis	0.00107	0.00569	CbGpPWpGaD
Ciclesonide—Chest pain—Simvastatin—atherosclerosis	0.00106	0.00569	CcSEcCtD
Ciclesonide—Arthralgia—Simvastatin—atherosclerosis	0.00106	0.00569	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—SIRT1—atherosclerosis	0.00105	0.00564	CbGpPWpGaD
Ciclesonide—Infection—Ezetimibe—atherosclerosis	0.00105	0.00569	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—FABP4—atherosclerosis	0.00105	0.00559	CbGpPWpGaD
Ciclesonide—Angioedema—Niacin—atherosclerosis	0.00104	0.00561	CcSEcCtD
Ciclesonide—CYP3A4—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.00104	0.00554	CbGpPWpGaD
Ciclesonide—Angioedema—Pravastatin—atherosclerosis	0.00102	0.00552	CcSEcCtD
Ciclesonide—Urticaria—Rosuvastatin—atherosclerosis	0.00101	0.00547	CcSEcCtD
Ciclesonide—Palpitations—Niacin—atherosclerosis	0.00101	0.00543	CcSEcCtD
Ciclesonide—Infection—Simvastatin—atherosclerosis	0.00101	0.00542	CcSEcCtD
Ciclesonide—Cough—Niacin—atherosclerosis	0.000994	0.00536	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000986	0.00532	CcSEcCtD
Ciclesonide—Cough—Pravastatin—atherosclerosis	0.000978	0.00528	CcSEcCtD
Ciclesonide—Arthralgia—Niacin—atherosclerosis	0.000969	0.00523	CcSEcCtD
Ciclesonide—Hypertension—Pravastatin—atherosclerosis	0.000968	0.00522	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000967	0.00521	CcSEcCtD
Ciclesonide—Dyspnoea—Lovastatin—atherosclerosis	0.000965	0.0052	CcSEcCtD
Ciclesonide—Chest pain—Pravastatin—atherosclerosis	0.000955	0.00515	CcSEcCtD
Ciclesonide—Arthralgia—Pravastatin—atherosclerosis	0.000955	0.00515	CcSEcCtD
Ciclesonide—Dyspepsia—Lovastatin—atherosclerosis	0.000953	0.00514	CcSEcCtD
Ciclesonide—CYP3A4—Farnesoid X Receptor  Pathway—CYP7A1—atherosclerosis	0.000949	0.00507	CbGpPWpGaD
Ciclesonide—Dry mouth—Niacin—atherosclerosis	0.000948	0.00511	CcSEcCtD
Ciclesonide—Dyspnoea—Ezetimibe—atherosclerosis	0.000946	0.0051	CcSEcCtD
Ciclesonide—Dyspepsia—Ezetimibe—atherosclerosis	0.000934	0.00504	CcSEcCtD
Ciclesonide—Fatigue—Lovastatin—atherosclerosis	0.000933	0.00503	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000922	0.00497	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000916	0.00494	CcSEcCtD
Ciclesonide—Asthenia—Rosuvastatin—atherosclerosis	0.000916	0.00494	CcSEcCtD
Ciclesonide—Fatigue—Ezetimibe—atherosclerosis	0.000915	0.00493	CcSEcCtD
Ciclesonide—Infection—Pravastatin—atherosclerosis	0.000909	0.0049	CcSEcCtD
Ciclesonide—Dyspnoea—Simvastatin—atherosclerosis	0.000902	0.00487	CcSEcCtD
Ciclesonide—Dyspepsia—Simvastatin—atherosclerosis	0.000891	0.0048	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptors—ESR2—atherosclerosis	0.00088	0.0047	CbGpPWpGaD
Ciclesonide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000874	0.00471	CcSEcCtD
Ciclesonide—Fatigue—Simvastatin—atherosclerosis	0.000873	0.00471	CcSEcCtD
Ciclesonide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—atherosclerosis	0.000871	0.00465	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—atherosclerosis	0.000866	0.00463	CbGpPWpGaD
Ciclesonide—Urticaria—Lovastatin—atherosclerosis	0.00086	0.00464	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—RETN—atherosclerosis	0.000859	0.00459	CbGpPWpGaD
Ciclesonide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000847	0.00457	CcSEcCtD
Ciclesonide—Dizziness—Rosuvastatin—atherosclerosis	0.000844	0.00455	CcSEcCtD
Ciclesonide—Urticaria—Ezetimibe—atherosclerosis	0.000843	0.00455	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000834	0.0045	CcSEcCtD
Ciclesonide—Dyspnoea—Niacin—atherosclerosis	0.000829	0.00447	CcSEcCtD
Ciclesonide—NR3C1—Circadian Clock—NAMPT—atherosclerosis	0.000818	0.00437	CbGpPWpGaD
Ciclesonide—Dyspepsia—Niacin—atherosclerosis	0.000818	0.00441	CcSEcCtD
Ciclesonide—Dyspnoea—Pravastatin—atherosclerosis	0.000816	0.0044	CcSEcCtD
Ciclesonide—Dyspepsia—Pravastatin—atherosclerosis	0.000805	0.00434	CcSEcCtD
Ciclesonide—Rash—Rosuvastatin—atherosclerosis	0.000805	0.00434	CcSEcCtD
Ciclesonide—Dermatitis—Rosuvastatin—atherosclerosis	0.000804	0.00434	CcSEcCtD
Ciclesonide—Urticaria—Simvastatin—atherosclerosis	0.000804	0.00434	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000802	0.00433	CcSEcCtD
Ciclesonide—Headache—Rosuvastatin—atherosclerosis	0.0008	0.00431	CcSEcCtD
Ciclesonide—Fatigue—Pravastatin—atherosclerosis	0.000789	0.00425	CcSEcCtD
Ciclesonide—Asthenia—Lovastatin—atherosclerosis	0.000776	0.00419	CcSEcCtD
Ciclesonide—NR3C1—Circadian Clock—F7—atherosclerosis	0.000776	0.00415	CbGpPWpGaD
Ciclesonide—Asthenia—Ezetimibe—atherosclerosis	0.000761	0.00411	CcSEcCtD
Ciclesonide—Nausea—Rosuvastatin—atherosclerosis	0.000758	0.00409	CcSEcCtD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—atherosclerosis	0.000754	0.00403	CbGpPWpGaD
Ciclesonide—Urticaria—Niacin—atherosclerosis	0.000738	0.00398	CcSEcCtD
Ciclesonide—Urticaria—Pravastatin—atherosclerosis	0.000727	0.00392	CcSEcCtD
Ciclesonide—Asthenia—Simvastatin—atherosclerosis	0.000726	0.00392	CcSEcCtD
Ciclesonide—Dizziness—Lovastatin—atherosclerosis	0.000716	0.00386	CcSEcCtD
Ciclesonide—Dizziness—Ezetimibe—atherosclerosis	0.000702	0.00378	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—ESR2—atherosclerosis	0.000696	0.00372	CbGpPWpGaD
Ciclesonide—Rash—Lovastatin—atherosclerosis	0.000682	0.00368	CcSEcCtD
Ciclesonide—Dermatitis—Lovastatin—atherosclerosis	0.000682	0.00368	CcSEcCtD
Ciclesonide—Headache—Lovastatin—atherosclerosis	0.000678	0.00366	CcSEcCtD
Ciclesonide—Dizziness—Simvastatin—atherosclerosis	0.000669	0.00361	CcSEcCtD
Ciclesonide—Rash—Ezetimibe—atherosclerosis	0.000669	0.00361	CcSEcCtD
Ciclesonide—Dermatitis—Ezetimibe—atherosclerosis	0.000669	0.00361	CcSEcCtD
Ciclesonide—Asthenia—Niacin—atherosclerosis	0.000667	0.0036	CcSEcCtD
Ciclesonide—Headache—Ezetimibe—atherosclerosis	0.000665	0.00359	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—SELE—atherosclerosis	0.000663	0.00354	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000657	0.00351	CbGpPWpGaD
Ciclesonide—Asthenia—Pravastatin—atherosclerosis	0.000657	0.00354	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—SERPINE1—atherosclerosis	0.000653	0.00349	CbGpPWpGaD
Ciclesonide—Nausea—Lovastatin—atherosclerosis	0.000643	0.00347	CcSEcCtD
Ciclesonide—Rash—Simvastatin—atherosclerosis	0.000638	0.00344	CcSEcCtD
Ciclesonide—Dermatitis—Simvastatin—atherosclerosis	0.000638	0.00344	CcSEcCtD
Ciclesonide—Headache—Simvastatin—atherosclerosis	0.000634	0.00342	CcSEcCtD
Ciclesonide—Nausea—Ezetimibe—atherosclerosis	0.00063	0.0034	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—HMOX1—atherosclerosis	0.000623	0.00333	CbGpPWpGaD
Ciclesonide—Dizziness—Niacin—atherosclerosis	0.000615	0.00331	CcSEcCtD
Ciclesonide—Dizziness—Pravastatin—atherosclerosis	0.000605	0.00326	CcSEcCtD
Ciclesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—atherosclerosis	0.000602	0.00322	CbGpPWpGaD
Ciclesonide—Nausea—Simvastatin—atherosclerosis	0.000601	0.00324	CcSEcCtD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000596	0.00318	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptors—PPARA—atherosclerosis	0.000589	0.00315	CbGpPWpGaD
Ciclesonide—Rash—Niacin—atherosclerosis	0.000586	0.00316	CcSEcCtD
Ciclesonide—Dermatitis—Niacin—atherosclerosis	0.000585	0.00316	CcSEcCtD
Ciclesonide—Headache—Niacin—atherosclerosis	0.000582	0.00314	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—GSTM1—atherosclerosis	0.000581	0.0031	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000578	0.00309	CbGpPWpGaD
Ciclesonide—Rash—Pravastatin—atherosclerosis	0.000577	0.00311	CcSEcCtD
Ciclesonide—Dermatitis—Pravastatin—atherosclerosis	0.000576	0.00311	CcSEcCtD
Ciclesonide—Headache—Pravastatin—atherosclerosis	0.000573	0.00309	CcSEcCtD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000571	0.00305	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—AGER—atherosclerosis	0.00056	0.00299	CbGpPWpGaD
Ciclesonide—Nausea—Niacin—atherosclerosis	0.000552	0.00298	CcSEcCtD
Ciclesonide—Nausea—Pravastatin—atherosclerosis	0.000544	0.00293	CcSEcCtD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—atherosclerosis	0.000543	0.0029	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000534	0.00286	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptors—ESR1—atherosclerosis	0.000534	0.00285	CbGpPWpGaD
Ciclesonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—atherosclerosis	0.000534	0.00285	CbGpPWpGaD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000527	0.00282	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000515	0.00275	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—atherosclerosis	0.000506	0.0027	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—PDGFB—atherosclerosis	0.0005	0.00267	CbGpPWpGaD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—atherosclerosis	0.000497	0.00266	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.000492	0.00263	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptors—PPARG—atherosclerosis	0.000487	0.0026	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—AHR—atherosclerosis	0.00047	0.00251	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.000469	0.00251	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000469	0.0025	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.000466	0.00249	CbGpPWpGaD
Ciclesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—atherosclerosis	0.000448	0.00239	CbGpPWpGaD
Ciclesonide—NR3C1—Circadian Clock—PPARA—atherosclerosis	0.000438	0.00234	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000433	0.00232	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—EDN1—atherosclerosis	0.000432	0.00231	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.000425	0.00227	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.000422	0.00225	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—EDN1—atherosclerosis	0.000422	0.00225	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.000418	0.00223	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL10—atherosclerosis	0.000417	0.00223	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—NAMPT—atherosclerosis	0.000411	0.0022	CbGpPWpGaD
Ciclesonide—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	0.000409	0.00219	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—atherosclerosis	0.0004	0.00214	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—atherosclerosis	0.000389	0.00208	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.000385	0.00206	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000378	0.00202	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000373	0.00199	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.000371	0.00198	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MMP1—atherosclerosis	0.000354	0.00189	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—APOE—atherosclerosis	0.000351	0.00188	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—AGT—atherosclerosis	0.00035	0.00187	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000349	0.00187	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000345	0.00184	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—ADIPOQ—atherosclerosis	0.000336	0.0018	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—ESR1—atherosclerosis	0.000327	0.00175	CbGpPWpGaD
Ciclesonide—NR3C1—Circadian Clock—SERPINE1—atherosclerosis	0.000326	0.00174	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—atherosclerosis	0.000323	0.00173	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—atherosclerosis	0.000312	0.00167	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000308	0.00164	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000306	0.00164	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—atherosclerosis	0.000291	0.00156	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CCL2—atherosclerosis	0.000288	0.00154	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.000284	0.00152	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—atherosclerosis	0.000284	0.00152	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000283	0.00151	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—SOCS3—atherosclerosis	0.00028	0.00149	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—atherosclerosis	0.00025	0.00134	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—LPL—atherosclerosis	0.000249	0.00133	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP7A1—atherosclerosis	0.000249	0.00133	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000246	0.00131	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IFNG—atherosclerosis	0.000245	0.00131	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.000239	0.00128	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—TGFB1—atherosclerosis	0.000237	0.00127	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP27A1—atherosclerosis	0.00023	0.00123	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.000228	0.00122	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000227	0.00121	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—PPARA—atherosclerosis	0.00022	0.00118	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.00022	0.00117	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	0.000216	0.00115	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—AGT—atherosclerosis	0.000213	0.00114	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000213	0.00114	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—LEP—atherosclerosis	0.000209	0.00112	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—NFKB1—atherosclerosis	0.000209	0.00112	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MMP9—atherosclerosis	0.000206	0.0011	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	0.000201	0.00107	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—PPARG—atherosclerosis	0.000182	0.000973	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	0.00018	0.00096	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—INS—atherosclerosis	0.000179	0.000954	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	0.000177	0.000944	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000176	0.000941	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—TGFB1—atherosclerosis	0.000174	0.000929	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IGF1—atherosclerosis	0.000173	0.000923	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.000171	0.000915	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.00017	0.000908	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—SERPINE1—atherosclerosis	0.000164	0.000876	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	0.000163	0.00087	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000161	0.000858	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	0.000154	0.000824	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	0.00015	0.000804	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000148	0.000793	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL6—atherosclerosis	0.000128	0.000684	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—PARP1—atherosclerosis	0.000127	0.000678	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—ESR2—atherosclerosis	0.00012	0.000642	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.00012	0.000641	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000115	0.000615	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	0.000113	0.000603	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—STAT3—atherosclerosis	0.000112	0.000597	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000107	0.000574	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	0.000105	0.000562	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	0.000104	0.000556	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TGFB1—atherosclerosis	0.000104	0.000553	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTM1—atherosclerosis	0.000103	0.000549	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTM1—atherosclerosis	0.000101	0.000542	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	9.75e-05	0.000521	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TNF—atherosclerosis	9.67e-05	0.000517	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	8.36e-05	0.000447	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	8.04e-05	0.00043	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IL6—atherosclerosis	7.8e-05	0.000417	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	7.29e-05	0.000389	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	7.29e-05	0.000389	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HSPA1B—atherosclerosis	6.85e-05	0.000366	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PLTP—atherosclerosis	6.85e-05	0.000366	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	6.74e-05	0.00036	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	6.72e-05	0.000359	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	6.65e-05	0.000355	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	6.63e-05	0.000354	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PARP1—atherosclerosis	6.11e-05	0.000326	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	5.99e-05	0.00032	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LTA4H—atherosclerosis	5.94e-05	0.000317	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCG8—atherosclerosis	5.94e-05	0.000317	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ESR2—atherosclerosis	5.78e-05	0.000309	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	4.77e-05	0.000255	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCG1—atherosclerosis	4.7e-05	0.000251	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SIRT1—atherosclerosis	4.66e-05	0.000249	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PLTP—atherosclerosis	4.48e-05	0.000239	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—FABP4—atherosclerosis	4.42e-05	0.000236	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LCAT—atherosclerosis	4.42e-05	0.000236	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOA4—atherosclerosis	4.33e-05	0.000232	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP7A1—atherosclerosis	4.26e-05	0.000228	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP27A1—atherosclerosis	3.94e-05	0.00021	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCG8—atherosclerosis	3.88e-05	0.000208	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LTA4H—atherosclerosis	3.88e-05	0.000208	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PPARA—atherosclerosis	3.87e-05	0.000207	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	3.73e-05	0.000199	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALOX15—atherosclerosis	3.73e-05	0.000199	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	3.73e-05	0.000199	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOA2—atherosclerosis	3.73e-05	0.000199	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCG5—atherosclerosis	3.69e-05	0.000197	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LPA—atherosclerosis	3.56e-05	0.00019	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ESR1—atherosclerosis	3.51e-05	0.000187	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—BGN—atherosclerosis	3.45e-05	0.000184	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOA5—atherosclerosis	3.41e-05	0.000182	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	3.29e-05	0.000176	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PPARG—atherosclerosis	3.2e-05	0.000171	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALOX5—atherosclerosis	3.17e-05	0.00017	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCG1—atherosclerosis	3.07e-05	0.000164	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LCAT—atherosclerosis	2.89e-05	0.000154	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—FABP4—atherosclerosis	2.89e-05	0.000154	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SERPINE1—atherosclerosis	2.88e-05	0.000154	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NAMPT—atherosclerosis	2.85e-05	0.000152	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOA4—atherosclerosis	2.83e-05	0.000151	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LIPC—atherosclerosis	2.83e-05	0.000151	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOC3—atherosclerosis	2.81e-05	0.00015	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LDLR—atherosclerosis	2.79e-05	0.000149	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	2.78e-05	0.000149	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CETP—atherosclerosis	2.73e-05	0.000146	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SCARB1—atherosclerosis	2.61e-05	0.00014	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	2.57e-05	0.000138	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HMGCR—atherosclerosis	2.47e-05	0.000132	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.44e-05	0.00013	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOA2—atherosclerosis	2.44e-05	0.00013	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.44e-05	0.00013	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.44e-05	0.00013	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCG5—atherosclerosis	2.41e-05	0.000129	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LPA—atherosclerosis	2.33e-05	0.000124	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—BGN—atherosclerosis	2.25e-05	0.00012	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOA5—atherosclerosis	2.23e-05	0.000119	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCA1—atherosclerosis	2.2e-05	0.000118	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.15e-05	0.000115	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.07e-05	0.000111	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.89e-05	0.000101	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MAPK3—atherosclerosis	1.88e-05	0.0001	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.86e-05	9.94e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LIPC—atherosclerosis	1.85e-05	9.88e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOC3—atherosclerosis	1.84e-05	9.82e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LDLR—atherosclerosis	1.83e-05	9.76e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOB—atherosclerosis	1.81e-05	9.66e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CETP—atherosclerosis	1.78e-05	9.53e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.76e-05	9.39e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LPL—atherosclerosis	1.73e-05	9.22e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.71e-05	9.13e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GPX1—atherosclerosis	1.68e-05	9e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CD36—atherosclerosis	1.64e-05	8.76e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.61e-05	8.62e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.55e-05	8.3e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPARA—atherosclerosis	1.52e-05	8.14e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AGT—atherosclerosis	1.48e-05	7.89e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOE—atherosclerosis	1.45e-05	7.73e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.44e-05	7.68e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CAV1—atherosclerosis	1.43e-05	7.66e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOA1—atherosclerosis	1.43e-05	7.64e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.31e-05	6.98e-05	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AKT1—atherosclerosis	1.27e-05	6.76e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPARG—atherosclerosis	1.26e-05	6.73e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—INS—atherosclerosis	1.24e-05	6.6e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.23e-05	6.59e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOB—atherosclerosis	1.18e-05	6.31e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.15e-05	6.14e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALB—atherosclerosis	1.13e-05	6.05e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LPL—atherosclerosis	1.13e-05	6.03e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GPX1—atherosclerosis	1.1e-05	5.88e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NOS3—atherosclerosis	1.08e-05	5.79e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CD36—atherosclerosis	1.07e-05	5.73e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.02e-05	5.43e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPARA—atherosclerosis	9.97e-06	5.33e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS2—atherosclerosis	9.91e-06	5.3e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AGT—atherosclerosis	9.65e-06	5.16e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOE—atherosclerosis	9.46e-06	5.05e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CAV1—atherosclerosis	9.37e-06	5.01e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOA1—atherosclerosis	9.35e-06	5e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	8.53e-06	4.56e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPARG—atherosclerosis	8.24e-06	4.4e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—INS—atherosclerosis	8.08e-06	4.32e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALB—atherosclerosis	7.41e-06	3.96e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NOS3—atherosclerosis	7.09e-06	3.79e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS2—atherosclerosis	6.48e-06	3.46e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AKT1—atherosclerosis	4.98e-06	2.66e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AKT1—atherosclerosis	3.26e-06	1.74e-05	CbGpPWpGaD
